Literature DB >> 9555042

Immunological assessment of the distribution of type VII adenylyl cyclase in brain.

N Mons1, M Yoshimura, H Ikeda, P L Hoffman, B Tabakoff.   

Abstract

The localization of the nine identified isoforms of adenylyl cyclase in brain has been largely based on determination of patterns of mRNA expression. A polyclonal antibody has now been developed that specifically recognizes Type VII adenylyl cyclase. This antibody was used for immunocytochemical analysis of the distribution of Type VII adenylyl cyclase in rat brain. Labeling of Type VII adenylyl cyclase was observed in several areas, including cerebellum, caudate-putamen, nucleus accumbens, hippocampus and cerebral cortex. In some of these areas, the staining of the adenylyl cyclase protein suggested the possibility of presynaptic localization. For example, in situ hybridization showed Type VII adenylyl cyclase mRNA concentrated in cerebellar granule neurons. The cerebellar granule cell layer, however, showed little immunostaining, while punctate immunostaining was observed in the molecular layer. These results suggested that protein synthesized in the granule neurons may be targeted to the neuron terminals. Punctate staining in the caudate-putamen, globus pallidus and nucleus accumbens also suggested the possibility of axonal and/or dendritic localization of Type VII adenylyl cyclase in these regions. Labeling of the soma of cerebellar Purkinje cells, cortical pyramidal and non-pyramidal cells and interneurons in the cerebellum and hippocampus was also observed. Type VII adenylyl cyclase, like the other adenylyl cyclase isoforms, has distinct regulatory characteristics, including sensitivity to stimulation by Gsalpha and G protein betagamma subunits, modulation by protein kinase C, and high sensitivity to stimulation by ethanol. These characteristics, and the discrete localization of this enzyme, may contribute to its ability to provide signal integration and/or control of neurotransmitter release in particular neurons or brain areas. Copyright 1998 Elsevier Science B.V.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9555042     DOI: 10.1016/s0006-8993(98)00005-5

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  7 in total

1.  Impaired D2 dopamine receptor function in mice lacking type 5 adenylyl cyclase.

Authors:  Ko-Woon Lee; Jang-Hee Hong; In Young Choi; Yongzhe Che; Ja-Kyeong Lee; Sung-Don Yang; Chang-Woo Song; Ho Sung Kang; Jae-Heun Lee; Jai Sung Noh; Hee-Sup Shin; Pyung-Lim Han
Journal:  J Neurosci       Date:  2002-09-15       Impact factor: 6.167

2.  Cellular localisation of adenylyl cyclase: a post-genome perspective.

Authors:  Ferenc A Antoni; Ulrich K Wiegand; Jamie Black; James Simpson
Journal:  Neurochem Res       Date:  2006-02       Impact factor: 3.996

Review 3.  Synaptic effects induced by alcohol.

Authors:  David M Lovinger; Marisa Roberto
Journal:  Curr Top Behav Neurosci       Date:  2013

4.  Temporal expression of calcium/calmodulin-dependent adenylyl cyclase isoforms in rat articular chondrocytes: RT-PCR and immunohistochemical localization.

Authors:  Ismail Memon; Khalid M Khan; Sammer Siddiqui; Siddiqa Perveen; Muhammad Ishaq
Journal:  J Anat       Date:  2010-11       Impact factor: 2.610

5.  Rapid signaling of estrogen in hypothalamic neurons involves a novel G-protein-coupled estrogen receptor that activates protein kinase C.

Authors:  Jian Qiu; Martha A Bosch; Sandra C Tobias; David K Grandy; Thomas S Scanlan; Oline K Ronnekleiv; Martin J Kelly
Journal:  J Neurosci       Date:  2003-10-22       Impact factor: 6.167

6.  Type 7 Adenylyl Cyclase is Involved in the Ethanol and CRF Sensitivity of GABAergic Synapses in Mouse Central Amygdala.

Authors:  Maureen T Cruz; Michal Bajo; M Elisabetta Maragnoli; Boris Tabakoff; George R Siggins; Marisa Roberto
Journal:  Front Neurosci       Date:  2011-01-14       Impact factor: 4.677

Review 7.  Expression and functions of adenylyl cyclases in the CNS.

Authors:  Karan Devasani; Yao Yao
Journal:  Fluids Barriers CNS       Date:  2022-03-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.